Stay updated on Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page’s software/release revision from v3.5.2 to v3.5.3, without changing the underlying study information shown on the record.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:38.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:30:50.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    - Revision log updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-20T00:10:54.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T21:16:12.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Update timestamps were added/adjusted on the page, reflecting recent edits to the record. No changes to the study design, eligibility criteria, or outcomes were observed.
    Difference
    0.3%
    Check dated 2026-02-19T05:33:56.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; notices for Revision: v3.4.1 and the government funding status alert were removed.
    Difference
    0.5%
    Check dated 2026-02-12T02:10:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.